Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million
09 nov. 2020 16h05 HE
|
Fulgent Genetics, Inc.
Third Quarter 2020 Results: Record Revenue of $101.7 million, growing more than 880% year-over-yearRecord Billable tests delivered approximately 1.04 million, growing more than 4,800%...
Fulgent Genetics to Announce Third Quarter 2020 Financial Results on Monday November 9, 2020
26 oct. 2020 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2020...
Fulgent Genetics Announces Partnership with Ohio Department of Rehabilitation and Correction for COVID-19 Testing
30 sept. 2020 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics to Provide COVID-19 Testing Solutions for the State of Utah
15 sept. 2020 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing
09 sept. 2020 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
04 sept. 2020 08h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics Adds Influenza A and Influenza B to all COVID-19 Tests
03 sept. 2020 06h00 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions...
Fulgent Genetics, New York City Health and Hospitals Partner on Large-Scale Back-to-School COVID-19 Testing
02 sept. 2020 16h05 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq: FLGT) and New York City Health and Hospitals have announced they will provide COVID-19 testing to hundreds of...
Fulgent Genetics Announces Expansion into Houston, TX
17 août 2020 07h00 HE
|
Fulgent Genetics, Inc.
CLIA-Certified Laboratory will Increase Testing CapacityRaising FY20 Revenue Guidance to $135 Million from $120 Million TEMPLE CITY, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc....
Fulgent Genetics Reports Record Second Quarter 2020 Financial Results
04 août 2020 16h05 HE
|
Fulgent Genetics, Inc.
Second Quarter 2020 Results: Record Revenue of $17.3 million, growing 105% year-over-yearRecord Billable tests delivered total 180,513, growing 1003% year-over-yearGross Margin improved approximately...